A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 233, 162-173
Abstract
No abstract availableKeywords
Funding Information
- Irish Research Council (1010-01)
- Science Foundation Ireland (SFI) (12/IA/1421)
- SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER) (SFI/12/RC/2278)
- European Union FP7 (FP7-SME-2012-1)
This publication has 49 references indexed in Scilit:
- Seasonal distribution and prevalence of diarrheagenic Escherichia coli in different aquatic environments in TaiwanEcotoxicology and Environmental Safety, 2016
- Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infantsVaccine, 2015
- Global Causes of Diarrheal Disease Mortality in Children <5 Years of Age: A Systematic ReviewPLOS ONE, 2013
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control studyThe Lancet, 2013
- Quantifying the Incidence and Burden of Postinfectious Enteric SequelaeMilitary Medicine, 2013
- Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illnessBMC Gastroenterology, 2013
- Molecular mechanisms of Escherichia coli pathogenicityNature Reviews Microbiology, 2009
- Enteric infections, diarrhea, and their impact on function and developmentJournal of Clinical Investigation, 2008
- Infectious Diarrhea in Developed and Developing CountriesJournal of Clinical Gastroenterology, 2005
- Colonization factors of human enterotoxigenic Escherichia coli (ETEC)Trends in Microbiology, 1996